Skip to main content
Top
Published in:

16-05-2024 | Human Immunodeficiency Virus | Original Paper

HIV Risk Behaviors and the Use of Geosocial Networking Dating Apps among Men Who have Sex with Men and Transgender Women in Lima, Peru: a Cross-Sectional Study

Authors: Elizabeth McQuade, Hugo Sánchez, José Hidalgo, Robinson Cabello, Rosario Fernandez, Jeb Jones, Ann Duerr, Alexander Lankowski

Published in: AIDS and Behavior | Issue 8/2024

Login to get access

Abstract

Geosocial networking dating apps (GSN apps) are an increasingly widespread technology used by populations throughout the world to facilitate sexual encounters. Studies from a variety of settings suggest a possible association between GSN app use and HIV risk behaviors, including among sexual and gender minority populations such as men who have sex with men (MSM) and transgender women (TW). However, it remains unclear to what extent GSN apps play a causal role. We explored the relationship between GSN app use and sexual risk behaviors among MSM and TW in Lima, Peru by analyzing data from a multi-site cross-sectional survey assessing both general and partner-specific sexual behaviors. We performed bivariate analysis to estimate the association of GSN app use with different individual and partner-specific factors, then fit multivariable regression models adjusting for age and education. Among 741 total participants (698 MSM, 43 TW), 64% met at least one sex partner in the prior three months using a GSN app. GSN app users were significantly more likely to report engaging in HIV risk behaviors in general, including condomless receptive anal sex, group sex, transactional sex, and sex under the influence of alcohol or drugs. Having condomless anal sex with a given partner was not associated with meeting that partner via GSN app. These findings highlight GSN app users as a particularly vulnerable subpopulation among MSM and TW in Lima. GSN apps could provide a useful vehicle for targeted HIV prevention efforts for priority populations in Peru.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference UNAIDS, Peru. 2022. Accessed February 1, 2024. UNAIDS, Peru. 2022. Accessed February 1, 2024.
7.
go back to reference Francisco LN, Queiroz AA, Lopes de Sousa ÁF, Evangelista de Araújo TM, Milanez, de Oliveira FB, Batista Moura ME, Reis RK. A Review of Risk Behaviors for HIV Infection by Men Who Have Sex With Men Through Geosocial Networking Phone Apps. J Assoc Nurses AIDS Care. 2017;28(5):807–818. https://doi.org/10.1016/j.jana.2017.03.009 Francisco LN, Queiroz AA, Lopes de Sousa ÁF, Evangelista de Araújo TM, Milanez, de Oliveira FB, Batista Moura ME, Reis RK. A Review of Risk Behaviors for HIV Infection by Men Who Have Sex With Men Through Geosocial Networking Phone Apps. J Assoc Nurses AIDS Care. 2017;28(5):807–818. https://​doi.​org/​10.​1016/​j.​jana.​2017.​03.​009
13.
go back to reference Centers for Disease Control and Prevention. HIV basics: HIV transmission. 2021. Centers for Disease Control and Prevention. HIV basics: HIV transmission. 2021.
39.
43.
Metadata
Title
HIV Risk Behaviors and the Use of Geosocial Networking Dating Apps among Men Who have Sex with Men and Transgender Women in Lima, Peru: a Cross-Sectional Study
Authors
Elizabeth McQuade
Hugo Sánchez
José Hidalgo
Robinson Cabello
Rosario Fernandez
Jeb Jones
Ann Duerr
Alexander Lankowski
Publication date
16-05-2024
Publisher
Springer US
Published in
AIDS and Behavior / Issue 8/2024
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-024-04362-7

Other articles of this Issue 8/2024

AIDS and Behavior 8/2024 Go to the issue

A quick guide to ECGs

Electrocardiography Training Course

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

Obesity Clinical Trial Summary

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more